ACE and obesity due to melanocortin 4 receptor deficiency: The data of the present study provide additional support for a role for the RAS in the control of energy balance and the potential for beneficial effects of ACE inhibitors as a therapeutic strategy for patients with obesity and concomitant hypertension.